# Advoca: CAIHL reassessment

September 8, 2026. Published AI-assisted draft.

Advoca lets patients and care partners record visits, ask questions, and share information. Its Washington consumer health policy ties free access to research consent, with paid access after withdrawal. The policy and homepage give conflicting accounts of audio processing.

## Scope and agency posture

Patient/carer-selected Advoca app for recording, preparation, health questions, and research participation. Vendor-hosted consumer assistance, with a distinct research-commercialization channel.

Posture: **Potentially agency-expanding, with research-access and processing qualifications**.

Axis: 84/100, retained provisionally. No numerical recalibration was performed.

## Sources and documented findings

- The [current homepage](https://advocahealth.com/) describes source-linked answers, a checkable transcript/recording, and patient sharing. It also claims audio never reaches its servers. These are vendor statements.

- The [consumer health policy](https://advocahealth.com/consumer-health-data-privacy-policy.html), sections 1 and 3, says free-tier use requires research consent, withdrawing it requires a paid subscription, and audio reaches cloud processors. Its stated scope is Washington consumers. The audio description conflicts with the homepage.

- The [terms](https://advocahealth.com/terms/), sections 7–9, recognize user-content ownership and separate research consent. Personal/private sharing is permitted, with restrictions on the service's own content.

## Patient authority

Inference from the documented workflow: Patients choose questions, records, and recipients. Consent withdrawal is documented but has a financial consequence for free-tier users. That is a substantive condition on continued access, not simply optional research alongside identical free service.

## Critical capacity

Editorial assessment: Source-linked answers and retained originals could help users check summaries and prepare challenges. Actual source matching and correction are untested.

## Informed control

Editorial assessment: The detailed policy enables scrutiny, but its account of processing differs from a prominent privacy promise. Research consent and model-training use should be visible before reliance.

## Assessment and limits

The baseline's broad free/optional-research characterization needs correction. Patient direction remains supported, while the consent-price linkage and conflicting audio claims justify a qualified posture rather than automatic high-confidence expansion.

Confidence: Medium for published conditions, low for implementation.

Remaining uncertainty: Whether the tier conditions apply identically outside Washington, actual audio routing, transcript correction, and post-anonymization withdrawal effects.

Published documentation is evidence of stated conditions, not proof of actual implementation. Unknowns did not receive automatic negative points. Funding, sponsorship, and public code do not determine agency by themselves.

## Review provenance

- Reviewer/model: OpenAI Codex / GPT-6.
- Method: Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
- Human review: Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
- Earlier review: 2026-06-08. [Historical assessment](https://github.com/hugooc/HugoScore/blob/7e0ba68fae543832fe5f19009448e473983f48a9/site/reports/advoca-health-caihl-report.md). Earlier claims are not automatically reverified by this publication.